ALPHA
Alpha Journal · Subject

Hair & Skin

Hair loss treatment and skin ageing — what slows them, and what is marketing.

15
articles
GT20029 for Hair Loss in Men: What the Trial Data Show So Far01
Hair & Skin · 10 min

GT20029 for Hair Loss in Men: What the Trial Data Show So Far

GT20029 is an investigational topical that destroys the androgen receptor in the scalp instead of blocking it. One 12-week phase 2 trial in 180 men is the entire efficacy record, and it is thinner than the headlines suggest.

Nov 12, 2026
Share
Dutasteride Once Weekly vs Daily: What the Half-Life Argument Gets Wrong02
Hair & Skin · 17 min

Dutasteride Once Weekly vs Daily: What the Half-Life Argument Gets Wrong

The case for taking dutasteride once a week rests on one number: a five-week half-life. That number is real, but it describes the drug at the blood levels daily dosing produces. At one capsule a week, dutasteride behaves like a different drug.

Nov 9, 2026
Share
Pyrilutamide Once Daily vs Twice Daily: Three Trials Tested It and None Published03
Hair & Skin · 12 min

Pyrilutamide Once Daily vs Twice Daily: Three Trials Tested It and None Published

The once-versus-twice-daily question about pyrilutamide has a better answer than most dosing debates in hair loss, because somebody actually designed trials to settle it. Three of them, with the right arms. The catch is that not one has posted results.

Nov 6, 2026
Share
Low-Level Laser vs Minoxidil04
Hair & Skin · 14 min

Low-Level Laser Therapy vs Minoxidil: Which Hair Restoration Option Actually Delivers in 2026?

Minoxidil remains the better-supported first-line treatment for androgenetic alopecia — more evidence, lower cost, and decades of safety data behind it.

Oct 26, 2026
Share
Dutasteride vs Finasteride05
Hair & Skin · 14 min

Topical Dutasteride vs Topical Finasteride: Which Wins for Hair Restoration in 2026?

Topical dutasteride produces greater improvements in hair density than topical finasteride in head-to-head trials, but finasteride has the larger evidence base, more predictable systemic exposure data, and — as of September 2026 — a cleaner regulatory track record for compounded…

Sep 23, 2026
Share
PP405 vs Minoxidil: 2026 Evidence06
Hair & Skin · 3 min

PP405 vs Minoxidil for Androgenetic Alopecia: What the 2026 Evidence Shows

PP405, a first-in-class topical mitochondrial pyruvate carrier inhibitor, produces faster visible regrowth than minoxidil in early trials — but minoxidil has decades of controlled-trial data behind it, and PP405 is not yet commercially available.

Sep 3, 2026
Share
Oral vs Topical Minoxidil07
Hair & Skin · 4 min

Oral Low-Dose Minoxidil vs Topical Minoxidil for Men: Which Route Wins in 2026?

Low-dose oral minoxidil (LDOM) and topical minoxidil produce broadly similar hair density gains in men with androgenetic alopecia — but they carry meaningfully different risk profiles, and the right choice depends on your tolerance for systemic side effects, not just efficacy.

Sep 2, 2026
Share
Pyrilutamide vs Finasteride08
Hair & Skin · 4 min

Pyrilutamide vs Finasteride for Men: Which Hair Loss Treatment Wins in 2026?

Finasteride is the proven standard for male androgenetic alopecia (AGA), backed by decades of randomized trial data — but pyrilutamide (KX-826) is emerging as a credible topical alternative that blocks androgen receptors locally without suppressing systemic DHT.

Aug 27, 2026
Share
Finasteride vs Dutasteride09
Hair & Skin · 3 min

Finasteride vs Dutasteride for Male Hair Loss: Which 5-Alpha Reductase Inhibitor Wins in 2026?

Dutasteride produces meaningfully greater hair density gains than finasteride — roughly 28 more hairs per target area over 24 weeks in pooled trials — but finasteride remains the only FDA-approved oral option for male pattern hair loss and carries a longer real-world safety…

Aug 25, 2026
Share
What Actually Slows Skin Aging10
Hair & Skin · 3 min

Men's Skincare in 2026: What Actually Slows Skin Aging and What Is Marketing Noise

Daily broad-spectrum sunscreen, prescription tretinoin, and niacinamide are the three interventions with the strongest clinical evidence for slowing visible skin aging in men.

Aug 13, 2026
Share
Highest-Return Biohacks for Men11
Hair & Skin · 4 min

Highest-Return Biohacks for Men in 2026: What Actually Moves the Needle

The interventions with the best effort-to-outcome ratio for men aren't exotic—they're a short list of pharmacologic, nutritional, and behavioral tools with solid trial data behind them. Here's where the evidence actually points.

Jul 24, 2026
Share
Do Collagen Supplements Work?12
Hair & Skin · 4 min

Do Collagen Supplements Actually Work? What the Human RCT Evidence Shows

Oral collagen supplements produce real, measurable benefits for skin elasticity, joint pain, and muscle gains in older men — but the effects are moderate, not dramatic, and depend heavily on dose, product type, and duration.

Jul 24, 2026
Share
Best Face Creams for Aging Men13
Hair & Skin · 4 min

The Best Evidence-Backed Face Creams for Men in Their 40s and 50s (2026)

Prescription tretinoin is the most rigorously tested topical anti-aging treatment available, and for men in their 40s and 50s dealing with wrinkles, sun spots, and rough texture, the evidence supports starting there.

Jul 15, 2026
Share
Does He Shou Wu Stop Hair Loss?14
Hair & Skin · 4 min

He Shou Wu and Hair Loss in 2026: Does the Science Match the Hype?

He Shou Wu (Polygonum multiflorum) hits androgenetic alopecia through at least four distinct biological pathways — and new research is finally explaining why a root used in Chinese medicine for over a millennium keeps showing up in serious hair-loss conversations.

Jun 25, 2026
Share
Deoxyribose Gel vs Minoxidil15
Hair & Skin · 7 min

Deoxyribose Gel vs Minoxidil for Hair Loss in Men: What the Research Shows in 2026

Minoxidil remains the only topical hair-loss treatment with decades of randomized-trial evidence and regulatory approval behind it. Deoxyribose gel is a genuinely interesting challenger — but as of mid-2026, every human trial is still recruiting, and men making treatment…

Jun 24, 2026
Share
Alpha Journal

One email a week. The research, not the hype.

What we published, what changed in the evidence, and what it means if you are on a protocol.

No spam, no selling your address. Unsubscribe in one click.

Run the numbers first

43 free calculators — dosing, cost per month, unit conversions. No email required.

Open the calculators